“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives

The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future drug markets. The cumulative duration of discovery f...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Holly, Hanison, James, Nirmalan, Niroshini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217350/
https://www.ncbi.nlm.nih.gov/pubmed/28248238
http://dx.doi.org/10.3390/proteomes4030028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217350/
https://www.ncbi.nlm.nih.gov/pubmed/28248238
http://dx.doi.org/10.3390/proteomes4030028

Ejemplares similares